Miebach E - Search Results

1

Link B, Miebach E, Vetter T, Schmitt D, Beck M, Meurer A. Link B, et al. Among authors: miebach e. Orthopade. 2008 Jan;37(1):24-30. doi: 10.1007/s00132-007-1178-0. Orthopade. 2008. PMID: 18210085 German.

2

Abnormal somatosensory evoked potentials indicate compressive cervical myelopathy in mucopolysaccharidoses.

Boor R, Miebach E, Brühl K, Beck M. Boor R, et al. Among authors: miebach e. Neuropediatrics. 2000 Jun;31(3):122-7. doi: 10.1055/s-2000-7495. Neuropediatrics. 2000. PMID: 10963098

3

Cumulative incidence rates of the mucopolysaccharidoses in Germany.

Baehner F, Schmiedeskamp C, Krummenauer F, Miebach E, Bajbouj M, Whybra C, Kohlschütter A, Kampmann C, Beck M. Baehner F, et al. Among authors: miebach e. J Inherit Metab Dis. 2005;28(6):1011-7. doi: 10.1007/s10545-005-0112-z. J Inherit Metab Dis. 2005. PMID: 16435194

4

[Lysosomal storage diseases - update and new therapeutic options].

Schöpfer K, Miebach E, Beck M, Pitz S. Schöpfer K, et al. Among authors: miebach e. Klin Monbl Augenheilkd. 2011 Feb;228(2):144-60. doi: 10.1055/s-0028-1109958. Epub 2010 Mar 22. Klin Monbl Augenheilkd. 2011. PMID: 20309790 Review. German.

5

Enzyme replacement therapy in heterozygous females with Fabry disease: results of a phase IIIB study.

Baehner F, Kampmann C, Whybra C, Miebach E, Wiethoff CM, Beck M. Baehner F, et al. Among authors: miebach e. J Inherit Metab Dis. 2003;26(7):617-27. doi: 10.1023/b:boli.0000005658.14563.77. J Inherit Metab Dis. 2003. PMID: 14707510 Clinical Trial.

6

Clinical characteristics of adults with slowly progressing mucopolysaccharidosis VI: a case series.

Thümler A, Miebach E, Lampe C, Pitz S, Kamin W, Kampmann C, Link B, Mengel E. Thümler A, et al. Among authors: miebach e. J Inherit Metab Dis. 2012 Nov;35(6):1071-9. doi: 10.1007/s10545-012-9474-1. Epub 2012 Mar 23. J Inherit Metab Dis. 2012. PMID: 22441840

7

The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy.

Whybra C, Kampmann C, Krummenauer F, Ries M, Mengel E, Miebach E, Baehner F, Kim K, Bajbouj M, Schwarting A, Gal A, Beck M. Whybra C, et al. Among authors: miebach e. Clin Genet. 2004 Apr;65(4):299-307. doi: 10.1111/j.1399-0004.2004.00219.x. Clin Genet. 2004. PMID: 15025723

8

Does enzyme replacement therapy influence the ocular changes in type VI mucopolysaccharidosis?

Pitz S, Ogun O, Arash L, Miebach E, Beck M. Pitz S, et al. Among authors: miebach e. Graefes Arch Clin Exp Ophthalmol. 2009 Jul;247(7):975-80. doi: 10.1007/s00417-008-1030-1. Epub 2009 Jan 22. Graefes Arch Clin Exp Ophthalmol. 2009. PMID: 19159944 Clinical Trial.

9

A 4-year study of the efficacy and tolerability of enzyme replacement therapy with agalsidase alfa in 36 women with Fabry disease.

Whybra C, Miebach E, Mengel E, Gal A, Baron K, Beck M, Kampmann C. Whybra C, et al. Among authors: miebach e. Genet Med. 2009 Jun;11(6):441-9. doi: 10.1097/GIM.0b013e3181a23bec. Genet Med. 2009. PMID: 19346951 Free article. Clinical Trial.

10

Onset and progression of the Anderson-Fabry disease related cardiomyopathy.

Kampmann C, Linhart A, Baehner F, Palecek T, Wiethoff CM, Miebach E, Whybra C, Gal A, Bultas J, Beck M. Kampmann C, et al. Among authors: miebach e. Int J Cardiol. 2008 Nov 28;130(3):367-73. doi: 10.1016/j.ijcard.2008.03.007. Epub 2008 Jun 24. Int J Cardiol. 2008. PMID: 18572264

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page